Extensively drug-resistant TB in Eastern Cape, South Africa: High mortality in HIV-negative and HIV-positive patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 2, 2011, Pages 146-152

  Kvasnovsky, Charlotte L ^a,b   Cegielski, J Peter ^c   Erasmus, Roshen ^d   Siwisa, N Olga ^d   Thomas, Khulile ^d   Der Walt, Martie L Van ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Jose Pearson Hospital   (South Africa)

Author keywords

extensively drug resistant; HIV; survival; treatmentrelated outcomes; tuberculosis; XDR TB

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIRETROVIRUS AGENT; CAPREOMYCIN; CYCLOSERINE; DAPSONE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TERIZIDONE;

ADULT; AFRICA; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG WITHDRAWAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM CULTURE; SPUTUM SMEAR; SURVIVAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SOUTH AFRICA; YOUNG ADULT;

EID: 79957956584     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821190a3     Document Type: Article

References (16)

1. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World: Fourth Global Report. Geneva, Switzerland: World Health Organization; 2008. (Report no. WHO/HTM/TB/2008.394).
2. Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Tuberculosis Drug Resistance Surveillance. Lancet. 2009;373: 1861-1873.
3. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrugresistant tuberculosis-the perfect storm. J Infect Dis. 2007;196(Suppl 1): S86-S107. (Pubitemid 47206088)
4. Gandhi NR, Moll A, Sturm, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575-1580. (Pubitemid 44780738)
5. Shah NS, Pratt R, Armstrong L, et al. Extensively drug-resistant tuberculosis in the United States, 1993-2007. J Am Med Assoc. 2008;300: 2153-2160.
6. Singh S, Sankar MM, Gopinath K. High rate of extensively drug-resistant tuberculosis in Indian AIDS patients. AIDS. 2007;21:2345-2347. (Pubitemid 350287463)
7. World Health Organization. Guidelines for the Treatment of Multi-Drug Resistant Tuberculosis. Geneva, Switzerland: World Health Organization; 2006.
8. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multi-drug resistant tuberculosis. Int J Tuberc Lung Dis. 2005;9:640-645. (Pubitemid 40826156)
9. Khan A, Sterling TR, Reves R, et al. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med. 2006; 174:344-348. (Pubitemid 44156615)
10. Keshavjee S, Gelmanova IY, Farmer PE, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008;372:1403-1409.
11. Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008;359:563-574.
12. Frieden TR, Sterling T, Pablos-Mendez, et al. The emergence of drugresistant tuberculosis is New York City. N Engl J Med. 1993;328: 521-526. (Pubitemid 23053827)
13. Munsiff SS, Li J, Cook SV, et al. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003. Clin Infect Dis. 2006;10: 639-648. (Pubitemid 43845025)
14. Somocurcio JG, Sotomayor A, Shin S, et al. Surgery for patients with drug-resistant tuberculosis: report of 121 patients receiving communitybased treatment in Lima, Peru. Thorax. 2007;62:416-421. (Pubitemid 46698391)
15. Kim BJ, Kang YS, Park SK. Activity of moxifloxacin against ofloxacinresistant Mycobacterium tuberculosis: a study of cross-resistance between ofloxacin and moxifloxacin. Tuberc Respir Dis. 2004;57:405-410. (Pubitemid 40179674)
16. Schiffer JT, Sterling TR. Timing of antiretroviral therapy in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defic Syndr. 2007;44:229-234. (Pubitemid 46292227)